Royal Bank of Canada »

Spyglass Pharma shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Spyglass Pharma shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0k 85 23.53

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
Vestal Point Capital
Deerfield Management Company
Millennium Management
Vanguard Capital Management
First Light Asset Management
Franklin Resources
Affinity Asset Advisors
Standard Life Aberdeen
BlackRock
Geode Capital Management
Monashee Investment Management

View all funds holding Spyglass Pharma